Related references
Note: Only part of the references are listed.The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer
Marianne Farnebo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Small-molecule inhibitors of MDM2 as new anticancer therapeutics
Michael P. Dickens et al.
SEMINARS IN CANCER BIOLOGY (2010)
Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
Tom Van Maerken et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
MDM2-Dependent Inhibition of p53 Is Required for Epstein-Barr Virus B-Cell Growth Transformation and Infected-Cell Survival
Eleonora Forte et al.
JOURNAL OF VIROLOGY (2009)
Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells
B. Renouf et al.
LEUKEMIA (2009)
BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death
Mark Wade et al.
CELL CYCLE (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
Jerry E. Chipuk et al.
TRENDS IN CELL BIOLOGY (2008)
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas
Grzegorz Sarek et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
MDM2 inhibitors for cancer therapy
Lyubomir T. Vassilev
TRENDS IN MOLECULAR MEDICINE (2007)
Concomitant inhibition of MDM2 and Bcl-2 protein function synergistically induce mitochondrial apoptosis in AML
Kensuke Kojima et al.
CELL CYCLE (2006)
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma
T Stühmer et al.
BLOOD (2005)
Connected to death: The (unexpurgated) mitochondrial pathway of apoptosis
D Spierings et al.
SCIENCE (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
YL Yang et al.
CANCER CELL (2005)
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX
T Grimm et al.
BLOOD (2005)
Transcription, apoptosis and p53: catch-22
M Schuler et al.
TRENDS IN GENETICS (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway
T Portis et al.
ONCOGENE (2004)
Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2
J O'Nions et al.
ONCOGENE (2003)
Role of genetic and epigenetic changes in Burkitt lymphoma
MS Lindström et al.
SEMINARS IN CANCER BIOLOGY (2002)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation
KM Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells
KM Murphy et al.
CELL DEATH AND DIFFERENTIATION (2000)
Share Paper
